Currently receiving an from analysts at Wolfe Research , with a price target of $7.
It maintains significant institutional interest, with roughly 31 hedge fund holders reported. :
It was also recognized as a top stock for day trading due to high relative volume. Value-Oriented Biotech Picks best biotech stocks to buy under $10
Searching for biotech stocks under $10 reveals several companies with strong analyst backing and significant upcoming catalysts. As of late 2025 and early 2026, the following stocks are frequently highlighted by financial experts for their growth potential: Top Rated Biotech Stocks Under $10 :
AI responses may include mistakes. For financial advice, consult a professional. Learn more Currently receiving an from analysts at Wolfe Research
: Noted for its inhaled therapy for pulmonary arterial hypertension and its recent pursuit of FDA pediatric approval.
: Highlighted for strengthening its global reach through strategic deals, such as the one with Kyowa Kirin. Learn more : Noted for its inhaled therapy
: Biotech stocks, particularly those under $10, are highly volatile and carry significant risk due to the clinical trial process. Experts like Warren Buffett often avoid the sector because there is no way to fully de-risk clinical trial outcomes.